FI913405A0 - In vitro preparering av fusionsproteiner. - Google Patents
In vitro preparering av fusionsproteiner.Info
- Publication number
- FI913405A0 FI913405A0 FI913405A FI913405A FI913405A0 FI 913405 A0 FI913405 A0 FI 913405A0 FI 913405 A FI913405 A FI 913405A FI 913405 A FI913405 A FI 913405A FI 913405 A0 FI913405 A0 FI 913405A0
- Authority
- FI
- Finland
- Prior art keywords
- protein
- biologically active
- amino acid
- terminal amino
- active protein
- Prior art date
Links
- 238000000338 in vitro Methods 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 abstract 7
- 102000004169 proteins and genes Human genes 0.000 abstract 7
- 229920001184 polypeptide Polymers 0.000 abstract 4
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 4
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 4
- 125000001433 C-terminal amino-acid group Chemical group 0.000 abstract 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 abstract 2
- 125000001429 N-terminal alpha-amino-acid group Chemical group 0.000 abstract 1
- 101710118538 Protease Proteins 0.000 abstract 1
- 101100053619 Yersinia enterocolitica yscF gene Proteins 0.000 abstract 1
- 108010067541 carboxypeptidase ysc-alpha Proteins 0.000 abstract 1
- 108020001507 fusion proteins Proteins 0.000 abstract 1
- 102000037865 fusion proteins Human genes 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/06—Preparation of peptides or proteins produced by the hydrolysis of a peptide bond, e.g. hydrolysate products
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/585—Calcitonins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/65—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
- C07K14/815—Protease inhibitors from leeches, e.g. hirudin, eglin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/58—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from fungi
- C12N9/60—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from fungi from yeast
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/50—Fusion polypeptide containing protease site
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
- C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
- C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Wood Science & Technology (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Toxicology (AREA)
- Mycology (AREA)
- Endocrinology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9015825 | 1990-07-18 | ||
| GB909015825A GB9015825D0 (en) | 1990-07-18 | 1990-07-18 | In vitro processing of fusion proteins |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| FI913405A0 true FI913405A0 (fi) | 1991-07-15 |
| FI913405A FI913405A (fi) | 1992-01-19 |
| FI106720B FI106720B (fi) | 2001-03-30 |
Family
ID=10679295
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI913405A FI106720B (fi) | 1990-07-18 | 1991-07-15 | Fuusioproteiinien valmistus in vitro |
Country Status (19)
| Country | Link |
|---|---|
| EP (1) | EP0467839B1 (fi) |
| JP (1) | JP3140488B2 (fi) |
| AT (1) | ATE141645T1 (fi) |
| AU (1) | AU651830B2 (fi) |
| CA (1) | CA2047119C (fi) |
| DE (1) | DE69121489T2 (fi) |
| DK (1) | DK0467839T3 (fi) |
| ES (1) | ES2091897T3 (fi) |
| FI (1) | FI106720B (fi) |
| GB (1) | GB9015825D0 (fi) |
| GR (1) | GR3020840T3 (fi) |
| HU (1) | HU216104B (fi) |
| IE (1) | IE73209B1 (fi) |
| NO (1) | NO303132B1 (fi) |
| NZ (1) | NZ238989A (fi) |
| PT (1) | PT98332B (fi) |
| SG (1) | SG49863A1 (fi) |
| TW (1) | TW209247B (fi) |
| ZA (1) | ZA915579B (fi) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5525491A (en) * | 1991-02-27 | 1996-06-11 | Creative Biomolecules, Inc. | Serine-rich peptide linkers |
| CA2213512A1 (en) * | 1995-12-22 | 1997-07-03 | Toray Industries, Inc. | Method for producing bioactive fusion protein |
| US6800726B1 (en) | 1996-11-01 | 2004-10-05 | Pioneer Hi-Bred International, Inc. | Proteins with increased levels of essential amino acids |
| US6265204B1 (en) | 1997-01-17 | 2001-07-24 | Genencor International, Inc. | DNA sequences, vectors, and fusion polypeptides for secretion of polypeptides in filamentous fungi |
| GB9716790D0 (en) | 1997-08-07 | 1997-10-15 | Creative Peptides Sweden Ab | Recombinant DNA molecules comprising multimeric copies of a gene sequence and expression thereof |
| WO2014138371A1 (en) | 2013-03-06 | 2014-09-12 | Glaxosmithkline Llc | Host cells and methods of use |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MC1834A1 (fr) * | 1986-07-10 | 1988-06-03 | Transgene Sa | Bloc fonctionnel d'adn et plasmide codant pour l'hirudine,levure transformee,procede de preparation de l'hirudine,hirudine obtenue et son utilisation |
| US5010182A (en) * | 1987-07-28 | 1991-04-23 | Chiron Corporation | DNA constructs containing a Kluyveromyces alpha factor leader sequence for directing secretion of heterologous polypeptides |
| DK105489D0 (da) * | 1989-03-03 | 1989-03-03 | Novo Nordisk As | Polypeptid |
-
1990
- 1990-07-18 GB GB909015825A patent/GB9015825D0/en active Pending
-
1991
- 1991-07-09 EP EP91810543A patent/EP0467839B1/en not_active Expired - Lifetime
- 1991-07-09 DE DE69121489T patent/DE69121489T2/de not_active Expired - Fee Related
- 1991-07-09 AT AT91810543T patent/ATE141645T1/de not_active IP Right Cessation
- 1991-07-09 DK DK91810543.8T patent/DK0467839T3/da active
- 1991-07-09 SG SG9607721A patent/SG49863A1/en unknown
- 1991-07-09 ES ES91810543T patent/ES2091897T3/es not_active Expired - Lifetime
- 1991-07-15 FI FI913405A patent/FI106720B/fi active
- 1991-07-16 AU AU80463/91A patent/AU651830B2/en not_active Ceased
- 1991-07-16 NZ NZ238989A patent/NZ238989A/en not_active IP Right Cessation
- 1991-07-16 PT PT98332A patent/PT98332B/pt not_active IP Right Cessation
- 1991-07-16 CA CA002047119A patent/CA2047119C/en not_active Expired - Lifetime
- 1991-07-17 ZA ZA915579A patent/ZA915579B/xx unknown
- 1991-07-17 JP JP03176552A patent/JP3140488B2/ja not_active Expired - Fee Related
- 1991-07-17 IE IE250191A patent/IE73209B1/en not_active IP Right Cessation
- 1991-07-17 TW TW080105554A patent/TW209247B/zh active
- 1991-07-17 HU HU2398/91A patent/HU216104B/hu not_active IP Right Cessation
- 1991-07-17 NO NO912803A patent/NO303132B1/no not_active IP Right Cessation
-
1996
- 1996-08-22 GR GR960402054T patent/GR3020840T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NO912803L (no) | 1992-01-20 |
| ZA915579B (en) | 1992-03-25 |
| NO912803D0 (no) | 1991-07-17 |
| PT98332A (pt) | 1992-05-29 |
| JP3140488B2 (ja) | 2001-03-05 |
| IE73209B1 (en) | 1997-05-07 |
| SG49863A1 (en) | 2002-03-19 |
| JPH04229188A (ja) | 1992-08-18 |
| FI106720B (fi) | 2001-03-30 |
| HUT58369A (en) | 1992-02-28 |
| DE69121489D1 (de) | 1996-09-26 |
| AU8046391A (en) | 1992-01-23 |
| EP0467839A1 (en) | 1992-01-22 |
| HU216104B (hu) | 1999-04-28 |
| FI913405A (fi) | 1992-01-19 |
| GR3020840T3 (en) | 1996-11-30 |
| GB9015825D0 (en) | 1990-09-05 |
| CA2047119A1 (en) | 1992-01-19 |
| AU651830B2 (en) | 1994-08-04 |
| HU912398D0 (en) | 1991-12-30 |
| ATE141645T1 (de) | 1996-09-15 |
| IE912501A1 (en) | 1992-01-29 |
| EP0467839B1 (en) | 1996-08-21 |
| NZ238989A (en) | 1992-09-25 |
| NO303132B1 (no) | 1998-06-02 |
| DK0467839T3 (da) | 1996-09-16 |
| TW209247B (fi) | 1993-07-11 |
| ES2091897T3 (es) | 1996-11-16 |
| DE69121489T2 (de) | 1997-02-27 |
| CA2047119C (en) | 2002-10-08 |
| PT98332B (pt) | 1999-01-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2124685T3 (es) | Variantes del inhibidor de la tripsina pancreatica bovina, su produccion y uso. | |
| DK105489D0 (da) | Polypeptid | |
| DK0815245T3 (da) | Bioaktive IL 12 fusionsproteiner | |
| DE69034091D1 (de) | Herstellung von Hämoglobin und Analogen davon in Nicht-Erythrozytzellen | |
| DE3788216D1 (de) | Gentechnologisch hergestellter pankreatischer sekretorischer Trypsininhibitor und seine Varianten. | |
| SE8801701D0 (sv) | Production technology based on enzymic method | |
| FI913405A (fi) | In vitro preparering av fusionsproteiner. | |
| MX167236B (es) | Peptidos sinteticos de timosina -1 y metodo para su obtencion | |
| DE3881023D1 (de) | Proteine, expressionsvektoren, die fuer solche proteine kodierende dna enthalten und zellen, die solche expressionsvektoren enthalten. | |
| ATE119914T1 (de) | Peptide, deren verwendung als immuno- suppressanten und verfahren zu deren herstellung. | |
| EP0297362A3 (de) | Human-Aprotinin, dessen Lys-Rest in Position 15 gegen einen anderen protogenen Aminosäurerest ausgetauscht ist | |
| NO911557L (no) | Fremgangsmaate for fremstilling av fremmedproteiner i streptomyceter. | |
| DE69014541D1 (de) | Chemisch modifizierte Allergene und Verfahren zu ihrer Herstellung. | |
| DE59108261D1 (de) | Peptide des HIV-gag Proteins, ihre Herstellung und Verwendung | |
| ATE110775T1 (de) | Verfahren zur herstellung von hirudin. | |
| ATE130872T1 (de) | Ancrod ähnliche proteine, ihre herstellung und verwendung. | |
| DK53290A (da) | Syntetiske gaer-leader-peptider | |
| ATE91303T1 (de) | Verfahren zur herstellung von peptiden durch spezifische spaltung von gentechnisch gewonnenen fusionsproteinen mit collagenasen. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| GB | Transfer or assigment of application |
Owner name: NOVARTIS AG |